TRANSMEDICS GROUP INC (TMDX)
NASDAQ • Healthcare
$90.69
+$2.34 (+2.6%)
Market open
Last close at August 18, 2026 at 20:00 UTC
Fundamentals Charts
About TRANSMEDICS GROUP INC
Name
TRANSMEDICS GROUP INC
CEO
Waleed H. Hassanein
Website
Industry
Healthcare
Year Founded
1998
Employees
898
TransMedics Group, Inc. develops and sells organ-preservation and transplant-support systems in the healthcare equipment field. Listed on the NASDAQ Global Market as TMDX, the company generated $605.5 million in FY2025 revenue from technology used to keep donor organs viable outside the human body under near-physiological conditions.
Fundamentals & Financials
Revenue (TTM)
$668.4M
Net Income (TTM)
$151.6M
EPS (TTM)
$4.42
ROA (TTM)
10.36%
Current Ratio
6.62
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Stay Ahead of the Market
Get premium market insights delivered directly to your inbox.
Quote Summary
Previous CloseDay Range$90.69$88.45 - $92.5
52 Week RangeAvg. Volume$60.11 - $156988.2K
Market CapP/E Ratio$3.1B20.5
Peers & Related Assets
GKOSGLAUKOS CORP
$184.15-0.8%
KYMRKYMERA THERAPEUTICS INC
$121.38-0.0%
IMVTIMMUNOVANT INC
$44.3+1.4%
BRKRBRUKER CORP
$56.86-1.4%
OSCROSCAR HEALTH INC CLASS A
$31.28-0.9%
INDVINDIVIOR PHARMACEUTICALS INC
$39.43+0.9%
OPCHOPTION CARE HEALTH INC
$23.41+0.2%
HNGEHinge Health, Inc.
AKROAkero Therapeutics, Inc.
NAMSNewAmsterdam Pharma Company N.V.